NASDAQ: OCX - OncoCyte Corporation

Yield per half year: -18.02%
Sector: Healthcare

Share chart OncoCyte Corporation


OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, biopharma, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies.

More details
The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Main settings

Выручка 1.6E-5
EBITDA -0.0217
Число акций ао 0.1108 млрд
P/S 7726.46
P/BV 18.24
Цена ао 3
ISIN US68235C1071
Change price per day: 0% (2.53)
Change price per week: -13.06% (2.91)
Change price per month: -15.1% (2.98)
Change price per 3 month: -24.48% (3.35)
Change price per half year: -18.02% (3.086)
Change price per year: +721.43% (0.308)
Change price per year to date: -2.32% (2.59)

All parameters ⇨



Title Value Grade
P/S 7726.46 1
P/BV 18.24 9
P/E 0 0
EV/EBITDA -4.96 0


Title Value Grade
ROA, % -56.57 0
ROE, % -147.6 0


Title Value Grade
Div yield, % 0 0
DSI 0 0


Title Value Grade
Debt/EBITDA -0.1151 10

Growth impulse

Title Value Grade
Profit growth, % 24.59 5
Share price growth, % 0 0
Dividend growth, % 0 0

Main owners

Institutions Volume Share, %
Broadwood Capital, Inc. 2509066 30.37
AWM Investment Company, Inc. 754286 9.13
Vanguard Group Inc 247873 3
Morgan Stanley 122973 1.49
Defender Capital, LLC 71650 0.87
Geode Capital Management, LLC 61482 0.74
Blackrock Inc. 60187 0.73
State Street Corporation 16289 0.2
Renaissance Technologies, LLC 12718 0.15

Similar companies

Company management

Head Job title Payment Year of birth
Mr. Joshua Riggs President, CEO & Director 373.2k 1983 (41 year)
Mr. James Liu Senior Director, Controller, Principal Accounting Officer & Interim Principal Financial Officer 192.48k 1996 (28 years)
Dr. Ekkehard Schutz M.D., Ph.D. Chief Science Officer N/A
Mr. Yuh-Min Chiang Ph.D. Senior Vice President of R&D and Product Development N/A
Ms. Sandra O'Donald Senior Vice President of Business Operations N/A
Dr. Michael D. West Ph.D. Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc. N/A 1953 (71 year)
Ms. Sara Riordan Director of Medical Education N/A
Mr. Peter Hong VP, General Counsel & Secretary N/A

About company

Address: United States, Irvine. CA, 15 Cushing - open in Google maps, open in Yandex maps
Phone: +tel:9494097600